Latest Insider Transactions at Biora Therapeutics, Inc. (BIOR)
This section provides a real-time view of insider transactions for Biora Therapeutics, Inc. (BIOR). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of BIORA THERAPEUTICS, INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of BIORA THERAPEUTICS, INC.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 15
2024
|
Eric D Esparbes Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
27,830
-4.61%
|
$0
$0.67 P/Share
|
|
Aug 15
2024
|
Clarke Neumann |
SELL
Payment of exercise price or tax liability
|
Direct |
26,629
-5.41%
|
$0
$0.67 P/Share
|
|
Aug 15
2024
|
Aditya P. Mohanty Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
70,883
-4.6%
|
$0
$0.67 P/Share
|
|
Jun 05
2024
|
Jeffrey D. Alter |
BUY
Grant, award, or other acquisition
|
Direct |
12,500
+28.38%
|
-
|
|
Jun 05
2024
|
Brian L. Kotzin |
BUY
Grant, award, or other acquisition
|
Direct |
12,500
+28.9%
|
-
|
|
Jun 05
2024
|
Jill Ann Howe |
BUY
Grant, award, or other acquisition
|
Direct |
12,500
+28.14%
|
-
|
|
Jun 05
2024
|
Lynne Powell |
BUY
Grant, award, or other acquisition
|
Direct |
12,500
+28.9%
|
-
|
|
Feb 15
2024
|
Aditya P. Mohanty Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
819,000
+34.73%
|
-
|
|
Feb 15
2024
|
Clarke Neumann |
BUY
Grant, award, or other acquisition
|
Direct |
230,000
+31.85%
|
-
|
|
Feb 15
2024
|
Eric D Esparbes Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
325,000
+35.0%
|
-
|
|
Sep 18
2023
|
Athyrium Opportunities Iii Co Invest 1 LP |
BUY
Grant, award, or other acquisition
|
Indirect |
9,235,281
+45.8%
|
-
|
|
Aug 15
2023
|
Clarke Neumann |
BUY
Grant, award, or other acquisition
|
Direct |
210,175
+44.49%
|
-
|
|
Aug 15
2023
|
Clarke Neumann |
SELL
Payment of exercise price or tax liability
|
Direct |
36,183
-41.02%
|
$108,549
$3.14 P/Share
|
|
Aug 15
2023
|
Aditya P. Mohanty Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
559,450
+43.71%
|
-
|
|
Aug 15
2023
|
Aditya P. Mohanty Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
117,881
-42.26%
|
$353,643
$3.14 P/Share
|
|
Aug 15
2023
|
Eric D Esparbes Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
219,650
+44.08%
|
-
|
|
Aug 15
2023
|
Eric D Esparbes Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
40,022
-40.41%
|
$120,066
$3.14 P/Share
|
|
Jun 14
2023
|
Jill Ann Howe |
BUY
Grant, award, or other acquisition
|
Direct |
12,500
+39.17%
|
-
|
|
Jun 14
2023
|
Jeffrey D. Alter |
BUY
Grant, award, or other acquisition
|
Direct |
12,500
+39.62%
|
-
|
|
Jun 14
2023
|
Lynne Powell |
BUY
Grant, award, or other acquisition
|
Direct |
12,500
+40.66%
|
-
|
|
Jun 14
2023
|
Brian L. Kotzin |
BUY
Grant, award, or other acquisition
|
Direct |
12,500
+40.66%
|
-
|
|
May 15
2023
|
Clarke Neumann |
SELL
Payment of exercise price or tax liability
|
Direct |
2,368
-2.61%
|
$7,104
$3.35 P/Share
|
|
May 15
2023
|
Eric D Esparbes Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,807
-2.76%
|
$8,421
$3.35 P/Share
|
|
May 15
2023
|
Aditya P. Mohanty Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
11,249
-3.88%
|
$33,747
$3.35 P/Share
|
|
Mar 15
2023
|
Clarke Neumann |
SELL
Payment of exercise price or tax liability
|
Direct |
10,683
-10.55%
|
$21,366
$2.56 P/Share
|
|
Mar 15
2023
|
Clarke Neumann |
BUY
Grant, award, or other acquisition
|
Direct |
79,634
+29.89%
|
-
|
|
Mar 15
2023
|
Eric D Esparbes Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
11,216
-9.92%
|
$22,432
$2.56 P/Share
|
|
Mar 15
2023
|
Eric D Esparbes Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
84,917
+28.75%
|
-
|
|
Mar 15
2023
|
Aditya P. Mohanty Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
22,252
-7.12%
|
$44,504
$2.56 P/Share
|
|
Mar 15
2023
|
Aditya P. Mohanty Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
200,429
+24.66%
|
-
|
|
Feb 15
2023
|
Eric D Esparbes Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
269
-0.95%
|
$807
$3.46 P/Share
|
|
Feb 15
2023
|
Clarke Neumann |
SELL
Payment of exercise price or tax liability
|
Direct |
84
-0.39%
|
$252
$3.46 P/Share
|
|
Jan 03
2023
|
Athyrium Opportunities Iii Co Invest 1 LP |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
42,362
-100.0%
|
-
|
|
Jan 03
2023
|
Jill Ann Howe |
SELL
Sale (or disposition) back to the issuer
|
Direct |
19
-100.0%
|
-
|
|
Jan 03
2023
|
Eric D Esparbes Chief Financial Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
95
-100.0%
|
-
|
|
Jan 03
2023
|
Surbhi Sarna Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
8
-100.0%
|
-
|
|
Jan 03
2023
|
Jeffrey D. Alter |
SELL
Sale (or disposition) back to the issuer
|
Direct |
65
-100.0%
|
-
|
|
Jan 03
2023
|
Lynne Powell |
SELL
Sale (or disposition) back to the issuer
|
Direct |
45
-100.0%
|
-
|
|
Jan 03
2023
|
Clarke Neumann |
SELL
Sale (or disposition) back to the issuer
|
Direct |
44
-100.0%
|
-
|
|
Jan 03
2023
|
Aditya P. Mohanty Chief Executive Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
178
-100.0%
|
-
|
|
Jan 03
2023
|
Brian L. Kotzin |
SELL
Sale (or disposition) back to the issuer
|
Direct |
44
-100.0%
|
-
|
|
Nov 15
2022
|
Eric D Esparbes Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,194
-0.73%
|
$0
$0.27 P/Share
|
|
Nov 15
2022
|
Aditya P. Mohanty Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
175,071
-5.88%
|
$0
$0.27 P/Share
|
|
Nov 15
2022
|
Clarke Neumann |
SELL
Payment of exercise price or tax liability
|
Direct |
4,529
-0.83%
|
$0
$0.27 P/Share
|
|
Nov 09
2022
|
Athyrium Opportunities Iii Co Invest 1 LP |
BUY
Open market or private purchase
|
Indirect |
12,506,250
+22.79%
|
-
|
|
Aug 15
2022
|
Clarke Neumann |
SELL
Payment of exercise price or tax liability
|
Direct |
1,355
-0.25%
|
$1,355
$1.04 P/Share
|
|
Aug 15
2022
|
Eric D Esparbes Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,952
-0.83%
|
$5,952
$1.04 P/Share
|
|
Jul 05
2022
|
Surbhi Sarna Director |
SELL
Open market or private sale
|
Direct |
7,517
-4.81%
|
$0
$0.61 P/Share
|
|
Jun 15
2022
|
Surbhi Sarna Director |
BUY
Grant, award, or other acquisition
|
Direct |
96,154
+38.09%
|
-
|
|
Jun 15
2022
|
Lynne Powell |
BUY
Grant, award, or other acquisition
|
Direct |
96,154
+40.09%
|
-
|